4.99
price up icon1.42%   0.07
after-market Dopo l'orario di chiusura: 4.99
loading
Precedente Chiudi:
$4.92
Aprire:
$4.955
Volume 24 ore:
1.35M
Relative Volume:
0.23
Capitalizzazione di mercato:
$1.49B
Reddito:
$38.03M
Utile/perdita netta:
$-146.40M
Rapporto P/E:
-9.5962
EPS:
-0.52
Flusso di cassa netto:
$-121.38M
1 W Prestazione:
+22.91%
1M Prestazione:
+49.85%
6M Prestazione:
+41.76%
1 anno Prestazione:
+60.97%
Intervallo 1D:
Value
$4.955
$5.04
Intervallo di 1 settimana:
Value
$3.87
$5.82
Portata 52W:
Value
$1.8906
$5.82

Abcellera Biologics Inc Stock (ABCL) Company Profile

Name
Nome
Abcellera Biologics Inc
Name
Telefono
(604) 559-9005
Name
Indirizzo
150 W 4TH AVENUE, VANCOUVER
Name
Dipendente
596
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-18
Name
Ultimi documenti SEC
Name
ABCL's Discussions on Twitter

Confronta ABCL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ABCL
Abcellera Biologics Inc
4.99 1.47B 38.03M -146.40M -121.38M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-07 Ripresa Leerink Partners Outperform
2024-08-20 Downgrade The Benchmark Company Buy → Hold
2024-02-22 Aggiornamento The Benchmark Company Hold → Buy
2023-12-05 Iniziato KeyBanc Capital Markets Overweight
2023-11-06 Downgrade The Benchmark Company Buy → Hold
2023-10-13 Ripresa Piper Sandler Overweight
2023-02-28 Iniziato Cowen Outperform
2022-12-15 Iniziato Goldman Buy
2022-11-16 Iniziato Truist Buy
2021-12-21 Iniziato The Benchmark Company Buy
2021-11-19 Iniziato Piper Sandler Overweight
2021-01-05 Iniziato BMO Capital Markets Outperform
2021-01-05 Iniziato Berenberg Buy
2021-01-05 Iniziato Credit Suisse Outperform
2021-01-05 Iniziato SVB Leerink Outperform
2021-01-05 Iniziato Stifel Buy
Mostra tutto

Abcellera Biologics Inc Borsa (ABCL) Ultime notizie

pulisher
05:41 AM

What drives AbCellera Biologics Inc. stock priceExceptional ROI - Autocar Professional

05:41 AM
pulisher
05:12 AM

AbCellera Biologics Inc. Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional

05:12 AM
pulisher
01:40 AM

AbCellera: Just Another Biotech Stock (NASDAQ:ABCL) - Seeking Alpha

01:40 AM
pulisher
12:23 PM

Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot - MSN

12:23 PM
pulisher
07:53 AM

Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? - MSN

07:53 AM
pulisher
Jul 22, 2025

What analysts say about AbCellera Biologics Inc. stockBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is AbCellera Biologics Inc. a good long term investmentExplosive capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

ABCL.O Surges 15.5% Intraday: A Deep Dive Into the Drivers Behind the Sharp Move - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ABCL Stock Surge: Opportunity or Caution? - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

AbCellera Biologics Stock (ABCL) Opinions on Recent Price Surge - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

AbCellera Biologics (ABCL) Surges 18.75% Intraday: What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025
pulisher
Jul 18, 2025

AbCellera Bets Big On AI Antibody Discovery And Partnerships - Finimize

Jul 18, 2025
pulisher
Jul 18, 2025

Abcellera Biologics stock hits 52-week high at $4.46 - Investing.com Australia

Jul 18, 2025
pulisher
Jul 14, 2025

AbCellera Biologics' Mysterious 8.7% Spike: What's Driving the Rally? - AInvest

Jul 14, 2025
pulisher
Jul 09, 2025

Leerink Partners Initiates Coverage on AbCellera Biologics with "Outperform" Rating and $5.00 Price Target - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Abcellera Biologics stock hits 52-week high at 4.09 USD By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

AbCellera's Strategic Pivot to Internal Pipelines Fuels Growth Potential in Antibody Therapies - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire

Jul 07, 2025
pulisher
Jul 07, 2025

Leerink Partners Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $5 - 富途牛牛

Jul 07, 2025
pulisher
Jul 07, 2025

Abcellera Biologics stock hits 52-week high at 4.09 USD - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

AbCellera Biologics' 6% Surge: A Technical & Order-Flow Deep Dive - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Leerink Partners assumes coverage on AbCellera stock with Outperform rating - Investing.com

Jul 07, 2025
pulisher
Jul 02, 2025

AbCellera Biologics' Mysterious 5.7% Spike: A Technical Deep Dive - AInvest

Jul 02, 2025
pulisher
Jun 30, 2025

AbCellera Biologics: Fueling Growth Through Strategic Partnerships and R&D Reinvention - AInvest

Jun 30, 2025
pulisher
Jun 25, 2025

AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology - Insider Monkey

Jun 25, 2025
pulisher
Jun 25, 2025

AbCellera Biologics Soars 11.41% on Partnerships, Innovation - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Why Did AbCellera Biologics Jump 12%? Unraveling the Mysterious Spike - AInvest

Jun 24, 2025
pulisher
Jun 18, 2025

AbCellera Biologics' 10.9% Surge Explained: Technical Momentum or Hidden Drivers? - AInvest

Jun 18, 2025
pulisher
Jun 13, 2025

AbCellera shareholders approve board election and auditor - Investing.com Australia

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera shareholders approve board election and auditor By Investing.com - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera Biologics Holds Annual Shareholder Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

AbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash Burn (ABCL) - Seeking Alpha

Jun 13, 2025

Abcellera Biologics Inc Azioni (ABCL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):